Replimune (REPL) Depreciation and Depletion (2020 - 2024)
Replimune (REPL) reported Depreciation and Depletion of $700000.0 for Q2 2024, up 16.67% on a YoY basis from $600000.0 in Q3 2023, and little changed sequentially from $700000.0 in Q4 2023.
Replimune (REPL) Depreciation and Depletion (2020 - 2024) Analysis & Trends
Replimune (REPL) has 5 years of Depreciation and Depletion data on file, last reported at $700000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Replimune | 970.73 Mn | 970.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 700,000.00 |
| Jun 30, 2024 | 700,000.00 |
| Dec 31, 2023 | 700,000.00 |
| Dec 31, 2023 | 700,000.00 |
| Sep 30, 2023 | 700,000.00 |
| Sep 30, 2023 | 700,000.00 |
| Jun 30, 2023 | 600,000.00 |
| Jun 30, 2023 | 600,000.00 |
| Dec 31, 2022 | 700,000.00 |
| Dec 31, 2022 | 700,000.00 |
| Sep 30, 2022 | 600,000.00 |
| Sep 30, 2022 | 600,000.00 |
| Jun 30, 2022 | 620,000.00 |
| Jun 30, 2022 | 620,000.00 |
| Dec 31, 2021 | 548,000.00 |
| Dec 31, 2021 | 548,000.00 |
| Sep 30, 2021 | 532,000.00 |
| Sep 30, 2021 | 532,000.00 |
| Jun 30, 2021 | 518,000.00 |
| Jun 30, 2021 | 518,000.00 |